CRISPR Therapeutics AG Annual Earnings Per Share, Basic in USD/shares from 2017 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
CRISPR Therapeutics AG quarterly/annual Earnings Per Share, Basic history and growth rate from 2017 to 2023.
  • CRISPR Therapeutics AG Earnings Per Share, Basic for the quarter ending September 30, 2024 was -1.01 USD/shares, a 28.4% increase year-over-year.
  • CRISPR Therapeutics AG Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -2.81 USD/shares, a 37% increase year-over-year.
  • CRISPR Therapeutics AG annual Earnings Per Share, Basic for 2023 was -1.94 USD/shares, a 76.8% increase from 2022.
  • CRISPR Therapeutics AG annual Earnings Per Share, Basic for 2022 was -8.36 USD/shares, a 268% decline from 2021.
  • CRISPR Therapeutics AG annual Earnings Per Share, Basic for 2021 was 4.97 USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2 +$6.42 +76.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-21
2022 -$8 -$13 -268% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-21
2021 $4.97 +$10.30 Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 -$5 -$7 -530% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $1.23 +$4.67 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 -$3 -$2 -101% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-16
2017 -$2 Jan 1, 2017 Dec 31, 2017 10-K 2020-02-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.